IMCR - immunocore.com O‘sish sur’atiga tuzatilgan narx-foyda

Immunocore Holdings plc (IMCR) kompaniyasining korporativ logotipi

Dori-darmonlarning mukammal sovuq zanjirli tashilishi ularning samaradorligini kafolatlab, aksiyalar o'sishi uchun asos yaratadi. PEG koeffitsiyenti ushbu jarayonning bozor qiymatini ko'rsatadi, bunda 0.00 ushbu metrikaning so'nggi qiymatini aks ettiradi. Barqarorlik poydevori Kimmtrak dori vositasining noyob TCR texnologiyalari va professionalizmi Immunocore Holdings plc (IMCR) intellektual kapitalini himoya qiluvchi elita immunologlar jamoasi tomonidan ta'minlanadi.

IMCR: Immunocore PLC PEG multiplikatori 04.07.2022 - 17.11.2026

Immunocore Holdings (IMCR) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:IMCR Immunocore Corp
Immunocore original mahsuloti

Kontrakt hamkorlari orqali T-hujayralar terapiyasi ta'minotining barqarorligi foyda dinamikasiga bevosita ta'sir ko'rsatadi, bu esa Immunocore Holdings plc (IMCR) kompaniyasining P/E koeffitsiyenti va o'sish sur'atlari o'rtasidagi bog'liqlikda aks etadi. Ushbu ko'rsatkich biznesning bozor qiymatini uning kengayishi bilan solishtiradi: birdan past qiymat aktivning qadrsizlanganini anglatadi, bu esa Immunocore Holdings plc (IMCR) ning innovatsion onkologik dori vositalarini kengaytirishga kiritilgan investitsiyalarning yuqori samaradorligini tasdiqlaydi.

Immunocore Holdings plc raqobatchilari

ImmunityBio, Inc. (IBRX) - Narxning sof foyda o‘sishiga nisbati|Janux Therapeutics Inc - Narx-foyda va o‘sish multiplikatori|Arcus Biosciences (RCUS) - O‘sish sur’atiga tuzatilgan narx-foyda|ZYME: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TNGX (Tango Therapeutics, Inc.)|IOVA: PEG multiplikatori|IMTX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati xencor.com|Narx-foyda va o‘sish multiplikatori compasstherapeutics.com (CMPX)|Narxning foydaga va o‘sish sur’atiga nisbati Replimune Group Inc (REPL)|Narx-foyda va o‘sish multiplikatori Lyell Immunopharma Inc LYEL|Innate Pharma SA - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Pyxis Oncology, Inc. PYXS|CGEN - Narxning foydaga va o‘sish sur’atiga nisbati|IOBT (iobiotech.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Sutro Biopharma, Inc (STRO) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda MiNK (INKT)|Narx-foyda va o‘sish multiplikatori HOWL|IMMX - Narxning sof foyda o‘sishiga nisbati|Narx-foyda va o‘sish multiplikatori ALXO (ALX Oncology Holdings)|CUE (Cue Biopharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori PDSB (PDS Biotechnology)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti SONN|MAIABiotech.com - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Liminatus|Lava Tx (LVTX) - Narxning foydaga va o‘sish sur’atiga nisbati|NextCure, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|LPTX (Leap Tx) - PEG multiplikatori|PEG multiplikatori intensitytherapeutics.com|Narxning foydaga va o‘sish sur’atiga nisbati senseibio.com (SNSE)|TOVX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Gritstone bio - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati kinetabio.com (KA)|NEXI - Narxning foydaga va o‘sish sur’atiga nisbati|Turnstone Biologics Corp - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|VCNX: PEG multiplikatori|Harpoon Therapeutics Corp (HARP) - PEG multiplikatori